Back to results
US 2006/0217304 A1Published application
Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
AssigneeConjuChem Biotechnologies Inc.
InventorsDominique Bridon, Nissab Boudjellab, Roger Leger, Martin Robitaille, Karen Thibaudeau, Julie Carette
Life of this patent
Estimating the term…
Abstract
This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular, this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastrointestinal functions, from any segment of the gastrointestinal tract, from the oesophagus to the anus.
Claims2
A gastrointestinal tissue growth promoter derivative comprising:
- a GLP-2 peptide or an analog or fragment thereof having gastrointestinal tissue growth promoting activity;
- and
- a reactive entity coupled to the peptide,
- the derivative being capable of covalently binding in vivo with a functionality on a blood component.
1 more element
2-19. (canceled)
Dependencies are inferred from the claim text.